Table 2 Quality of assessment for included trials

Study	Pathology	A	B	C	D	E	F	G	H	I	Total/18	Quality assessment	Allocation concealment
Kim et al. [35]	PF	1	1	0	0	2	2	2	2	2	12	Moderate	B
Lyftogt [30]	AT	0	0	0	0	0	0	1	2	2	5	Poor	C
Lyftogt [31]	AT	0	0	0	0	0	0	1	1	2	4	Poor	C
Maxwell et al. [32]	AT	0	1	0	0	0	2	2	2	2	9	Moderate	C
Ryan et al. [36]	PF	0	2	0	0	0	2	2	1	2	9	Moderate	C
Ryan et al. [33]	AT	0	1	0	0	0	2	1	1	2	7	Moderate	C
Topol et al. [37]	OSD	1	2	1	1	1	2	2	2	2	14	Good	B
Yelland et al. [34]	AT	2	2	2	0	0	2	2	2	2	14	Good	A

PF Plantar fasciopathy, AT Achilles tendinopathy, OSD Osgood-Schlatter disease, A concealed assignment, B withdrawals described, intention to treat analysis, C assessors blinded, D participant blinded, E groups comparable at entry, F identical care programs, G inclusions/exclusions defined, H interventions defined, I outcomes defined

ISSN: 1757-1146